Role of matrix metalloproteinases in viral-associated glomerulonephritis

Nephrology Dialysis Transplantation

Volumn 24, Issue 4, 2009, Pages 1113-1121

  Wörnle, Markus ^a,b   Roeder, Maximilian ^a   Sauter, Matthias ^a   Ribeiro, Andrea ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

MMP 2; MMP 9; RIG I; TIMP 1; Toll like receptor 3

Indexed keywords

GELATINASE A; GELATINASE B; RETINOIC ACID INDUCIBLE PROTEIN I; SMALL INTERFERING RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TOLL LIKE RECEPTOR 3; VIRUS RNA;

ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; DOSE RESPONSE; GLOMERULONEPHRITIS; HUMAN; HUMAN CELL; KIDNEY FIBROSIS; MESANGIUM CELL; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; VIRUS; VIRUS INFECTION;

CELLS, CULTURED; GLOMERULONEPHRITIS; HUMANS; MATRIX METALLOPROTEINASES; MESANGIAL CELLS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 65349166919     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn627     Document Type: Article

References (36)

1. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl JMed 1992; 327: 1490-1495
2. Meyers CM, Seef LB, Stehman-Breen CO et al. Hepatitis C and renal disease: an update. Am J Kidney Dis 2003; 42: 631-657
3. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987; 64: 709-727
4. Klotman PE. HIV-associated nephropathy. Kidney Int 1999; 56: 1161- 1176
5. Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992; 20: 1-17
6. Floege J, Gr̈one HJ. Progression of renal failure: what is the role of cytokines? Nephrol Dial Transplant 1995; 10: 1575-1586
7. Weber M. Basement membrane proteins. Kidney Int 1992; 41: 620- 628
8. Bauvois B,Mothu N, Nguyen J et al. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGFbeta1 in patients with distinct types of primary glomerulonephritis. Nephrol Dial Transplant 2007; 22: 1115-1122
9. Lenz O, Elliot SJ, Stetler-Stevenson WG. Matrix metalloproteinases in renal development and disease. J Am Soc Nephrol 2000; 11: 574- 581
10. Kuroda T, Yoshida Y, Kamiie J et al. Expression of MMP-9 in mesangial cells and its changes in anti-GBM glomerulonephritis in WKY rats. Clin Exp Nephrol 2004; 8: 206-215
11. Sternlicht MD, Werb Z. Gelatinases (MMPs 2 and 9). In: Kreis T, Vale R (eds). Guidebook to the Extracellular Matrix, Anchor, and Adhesion Proteins. 2nd edn. Oxford: A Sambrook & Tooze Publication at Oxford University Press, 1999, 529-531
12. Baricos WH. Chronic renal disease: do metalloproteinase inhibitors have a demonstrable role in extracellular matrix accumulation? Curr Opin Nephrol Hypertens 1995; 4: 365-368
13. Koide H, Nakamura T, Ebihara I et al. Increased mRNA expression of metalloproteinase-9 in peripheral blood monocytes from patients with immunoglobulin A nephropathy. Am J Kidney Dis 1996; 28:32-39
14. Sanders JS, van Goor H, Hanemaaijer R et al. Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis. Nephrol Dial Transplant 2004; 19: 1412-1419
15. Ebihara I, Nakamura T, Shimada N et al. Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus. Am J Kidney Dis 1998; 32: 544-550
16. Liu BC, Zhang L, Lv LL et al. Application of antibody array technology in the analysis of urinary cytokine profiles in patients with chronic kidney disease. Am J Nephrol 2006; 26: 483-490
17. Nee L, Tuite N, Ryan MP et al. TNF-alpha and IL-1 beta-mediated regulation of MMP-9 and TIMP-1 in human glomerular mesangial cells. Nephron Exp Nephrol 2007; 107: 73-86
18. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2: 675- 680
19. Anders HJ, Banas B, Schl̈ondorff D. Signaling danger: toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol2004; 15: 854-867
20. MatsumotoM, Kikkawa S, KohaseMet al. Establishment of a monoclonal antibody against human toll-like receptor 3 that blocks doublestranded RNA-mediated signaling. Biochem Biophys Res Commun2002; 293: 1364-1369
21. Alexopoulou L, Holt AC, Medzhitov R et al. Recognition of doublestranded RNA and activation of NF-κB by toll-like receptor 3. Nature2001; 413: 732-738
22. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000; 68: 7010-7017
23. Akira S. Toll-like receptors and innate immunity. Adv Immun 2001; 78: 1-56
24. Vitour D, Meurs EF. Regulation of interferon production by RIG-I and LGP2: a lesson in self-control. Sci STKE 2007; 384: 20
25. ẄornleM, Schmid H, Banas B et al. Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol 2006; 168: 370-385
26. Uchiyama-Tanaka Y, Mori Y, Kishimoto N et al. Membranous glomerulonephritis associated with hepatitis C virus infection: case report and literature review. Clin Nephrol 2004; 61: 144-150
27. Banas B, Luckow B, Moller M et al. Chemokine and chemokine receptor expression in a novel human mesangial cell line. J Am Soc Nephrol 1999; 10: 2314-2322
28. Porubsky S, Schmid H, Bonrouhi M et al. Influence of native and hypochlorite-modified low-density lipoprotein on gene expression in human proximal tubular epithelium. Am J Pathol 2004; 164: 2175- 2187
29. Matsukura S, Kokubu F, Kurokawa M et al. Role of RIG-I, MDA-5, and PKR on the expression of inflammatory chemokines induced by synthetic dsRNA in airway epithelial cells. Int Arch Allergy Immunol2007; 143(Suppl 1): 80-83
30. Urushihara M, Kagami S, Kuhara T et al. Glomerular distribution and gelatinolytic enzymes of the matrix metalloproteinase family in the remodelling cornea. Nephrol Dial Transplant 2002; 17: 1189-1196
31. Matsumoto M, Funami K, Tanabe M et al. Subcellular localization of toll-like receptor 3 in human dendritic cells. J Immunol 2003; 171: 3154-3162
32. Marshall-Clarke S, Downes JE, Haga IR et al. Polyinosinic acid is a ligand for toll-like receptor 3. J Biol Chem 2007; 282: 24759-24766
33. Matsubara M, Girard MT, Kublin CL et al. Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodelling cornea. Dev Biol 1991; 147: 425-439
34. Okamoto K, Mandai M, Mimura K et al. The association of MMP-1, -3 and -9 genotypes with the prognosis of HCV-related hepatocellular carcinoma patients. Res Commun Mol Pathol Pharmacol 2005; 117- 118: 77-89
35. Shin JY, Hur W, Wang JS et al. HCV coreprotein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta1. Exp Mol Med 2005; 37: 138-145
36. Patole P, Gr̈one HJ, Segerer S et al. Viral double-stranded RNA aggravates lupus nephritis through toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells. J Am Soc Nephrol 2005; 16: 1326-1338